| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1379378 | Bioorganic & Medicinal Chemistry Letters | 2005 | 4 Pages |
Fluoroalkyl and fluoroaryl analogues of valdecoxib were found to possess potent inhibitory activities against cyclooxygenase-2 comparable to that of the parent valdecoxib. Among them, the fluoromethyl analogue was chosen for 18F-labeling. Thus, 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide (∼2000 Ci/mmol at end of synthesis) was synthesized by [18F]fluoride-ion displacement of the corresponding tosylate in ∼40% decay-corrected radiochemical yield within ∼120 min from end of bombardment.
Graphical abstractThe [18F]fluoromethyl analogue of valdecoxib (∼2000 Ci/mmol) was synthesized by [18F]fluoride-ion displacement of the corresponding tosylate in ∼40% decay-corrected radiochemical yield within ∼120 min from end of bombardment.Figure optionsDownload full-size imageDownload as PowerPoint slide
![First Page Preview: Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography Synthesis of 4-(5-[18F]fluoromethyl-3-phenylisoxazol-4-yl)benzenesulfonamide, a new [18F]fluorinated analogue of valdecoxib, as a potential radiotracer for imaging cyclooxygenase-2 with positron emission tomography](/preview/png/1379378.png)